iboga

Powerful psychedelic drug ibogaine could help people kick opioid addictions

Ross Pomeroy | 
Somewhere around two million Americans suffer from opioid-related substance use disorder. Treatments like buprenorphine and methadone calm the brain circuits affected by opioids, reducing ...
tci shrm feat image

Seeking mainstream acceptance for psychedelic drugs: Will entrepreneurs ruin it for everyone else?

Tessa Love | 
After spending decades as highly illegal and restricted substances, psilocybin (magic mushrooms), LSD, MDMA, DMT, and other psychedelic drugs are ...
psyy x

Trends that will shape the 2020s: Psychedelics as medicine, diagnostic cell phone apps and AI prediction of disease outbreaks

Katherine Wu, Rachael Lallensack | 
Clearly, a lot can happen in a decade—but innovation has to start somewhere. Based on what’s breaking through now, here ...
psillow header x microdosing x

Video: Placebo effect or powerful antidepressant? Understanding the science of psychedelic microdosing

Individuals who microdose mushrooms, or those who microdose LSD, claim to experience an elevated mood, increased productivity, and a greater ...
psychonauts

Psychedelics have ‘extraordinarily potent’ anti-inflammatory power. Is there a place for them in mainstream medicine?

Shlomi Raz | 
Research on psychedelics, which have been profoundly stigmatized, highly restricted, and tragically undeveloped for more than half a century, is ...
gettyimages

Taking psychoactive drugs can mirror near death experiences, study shows

Robert Martone | 
In a fascinating new study, [near-death experience] stories were compared linguistically with anecdotes of drug experience in order to identify a ...
nym microdosing x

Chasing a brain boost through psychedelic microdosing? Scientific support is ‘patchy, lacking’, review says

Ryan O'Hare | 
The practice of taking small, regular doses of psychedelic drugs to enhance mood, creativity, or productivity lacks robust scientific evidence ...
ap x

Inside the quest to find a place in modern medicine for magic mushrooms as a treatment for depression, other mental illnesses

Meghana Keshavan | 
Today, with a net worth of roughly $400 million accrued through various enterprises, [German financier Christian] Angermayer is one of ...
mushrooms x

How the rush to decriminalize magic mushrooms could hurt psychedelic drug research

Matt Simon | 
Welcome to a murky new front in the war to bring psychedelics out of the shadows and into both legal ...
maxresdefault

Explaining hallucinations through math

Jennifer Ouellette | 
[Researcher Heinrich Klüver] classified [hallucinogenic patterns he experienced] into four distinct types that he dubbed “form constants”: lattices (including checkerboards, ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists